Cyclic Peptides As C5a Receptor Antagonists
The invention relates to cyclic peptide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to cyclic peptide C5a receptor antagonists of formula (Ia)or formula...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Hepworth, David Hayward, Matthew Merrill Papaioannou, Nikolaos Jones, Peter Neelu, Kaila Che, Ye Feng, Yiqing |
description | The invention relates to cyclic peptide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to cyclic peptide C5a receptor antagonists of formula (Ia)or formula (Ib), or pharmaceutically acceptable salts thereof,wherein R1a, R1b, R2, R3 and R4 areas defined in the description. C5a receptor antagonists are potentially useful in the treatment of a wide range of 1 disorders,including inflammatory disorders and immune disorders. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2019270778A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2019270778A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2019270778A13</originalsourceid><addsrcrecordid>eNrjZNB2rkzOyUxWCEgtKMlMSS1WcCxWcDZNVAhKTQaK5BcpOOaVJKbn52UWlxTzMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL40GAjA0NLI3MDc3MLR0Nj4lQBAKr-Ka0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Cyclic Peptides As C5a Receptor Antagonists</title><source>esp@cenet</source><creator>Hepworth, David ; Hayward, Matthew Merrill ; Papaioannou, Nikolaos ; Jones, Peter ; Neelu, Kaila ; Che, Ye ; Feng, Yiqing</creator><creatorcontrib>Hepworth, David ; Hayward, Matthew Merrill ; Papaioannou, Nikolaos ; Jones, Peter ; Neelu, Kaila ; Che, Ye ; Feng, Yiqing</creatorcontrib><description>The invention relates to cyclic peptide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to cyclic peptide C5a receptor antagonists of formula (Ia)or formula (Ib), or pharmaceutically acceptable salts thereof,wherein R1a, R1b, R2, R3 and R4 areas defined in the description. C5a receptor antagonists are potentially useful in the treatment of a wide range of 1 disorders,including inflammatory disorders and immune disorders.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190905&DB=EPODOC&CC=US&NR=2019270778A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190905&DB=EPODOC&CC=US&NR=2019270778A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Hepworth, David</creatorcontrib><creatorcontrib>Hayward, Matthew Merrill</creatorcontrib><creatorcontrib>Papaioannou, Nikolaos</creatorcontrib><creatorcontrib>Jones, Peter</creatorcontrib><creatorcontrib>Neelu, Kaila</creatorcontrib><creatorcontrib>Che, Ye</creatorcontrib><creatorcontrib>Feng, Yiqing</creatorcontrib><title>Cyclic Peptides As C5a Receptor Antagonists</title><description>The invention relates to cyclic peptide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to cyclic peptide C5a receptor antagonists of formula (Ia)or formula (Ib), or pharmaceutically acceptable salts thereof,wherein R1a, R1b, R2, R3 and R4 areas defined in the description. C5a receptor antagonists are potentially useful in the treatment of a wide range of 1 disorders,including inflammatory disorders and immune disorders.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB2rkzOyUxWCEgtKMlMSS1WcCxWcDZNVAhKTQaK5BcpOOaVJKbn52UWlxTzMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL40GAjA0NLI3MDc3MLR0Nj4lQBAKr-Ka0</recordid><startdate>20190905</startdate><enddate>20190905</enddate><creator>Hepworth, David</creator><creator>Hayward, Matthew Merrill</creator><creator>Papaioannou, Nikolaos</creator><creator>Jones, Peter</creator><creator>Neelu, Kaila</creator><creator>Che, Ye</creator><creator>Feng, Yiqing</creator><scope>EVB</scope></search><sort><creationdate>20190905</creationdate><title>Cyclic Peptides As C5a Receptor Antagonists</title><author>Hepworth, David ; Hayward, Matthew Merrill ; Papaioannou, Nikolaos ; Jones, Peter ; Neelu, Kaila ; Che, Ye ; Feng, Yiqing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2019270778A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Hepworth, David</creatorcontrib><creatorcontrib>Hayward, Matthew Merrill</creatorcontrib><creatorcontrib>Papaioannou, Nikolaos</creatorcontrib><creatorcontrib>Jones, Peter</creatorcontrib><creatorcontrib>Neelu, Kaila</creatorcontrib><creatorcontrib>Che, Ye</creatorcontrib><creatorcontrib>Feng, Yiqing</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Hepworth, David</au><au>Hayward, Matthew Merrill</au><au>Papaioannou, Nikolaos</au><au>Jones, Peter</au><au>Neelu, Kaila</au><au>Che, Ye</au><au>Feng, Yiqing</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Cyclic Peptides As C5a Receptor Antagonists</title><date>2019-09-05</date><risdate>2019</risdate><abstract>The invention relates to cyclic peptide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to cyclic peptide C5a receptor antagonists of formula (Ia)or formula (Ib), or pharmaceutically acceptable salts thereof,wherein R1a, R1b, R2, R3 and R4 areas defined in the description. C5a receptor antagonists are potentially useful in the treatment of a wide range of 1 disorders,including inflammatory disorders and immune disorders.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2019270778A1 |
source | esp@cenet |
subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Cyclic Peptides As C5a Receptor Antagonists |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T13%3A02%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Hepworth,%20David&rft.date=2019-09-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2019270778A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |